Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-23

Clinical Trial Update: Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

Phase 4 study updating safety and effectiveness of Acthar Gel in participants with rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acthar Gel (repository corticotropin injection)

Snippet

Sponsor: Mallinckrodt | Conditions: Arthritis, Rheumatoid | Phase 4 | Status: COMPLETED | Results posted: 2020-03-23